You just read:

CVRx® Announces that the First Two Patients were Treated in the Phase III Pivotal Trial Evaluating BAROSTIM THERAPY® for the Treatment of Heart Failure

News provided by

CVRx, Inc.

06 Jun, 2016, 10:25 ET